Grifols seeks looser terms in $5.3bn refi launch

nurses right size
By Karoliina Liimatainen
29 Oct 2019

Spanish pharmaceutical company Grifols is planning to take advantage of balmy market conditions with a refinancing package that will replace most of its outstanding debt. The package will consist of a $3bn term loan B in dollars, a $1.6bn TLB in euros and $1.25bn of senior secured bonds issued in euros.

The TLBs will have a tenor of eight years. The roadshow for the bond will be launched later.

With the new loans and notes, Grifols wants to reduce the cost of debt, increase maturities and improve flexibility in terms, the company said in a statement on Tuesday ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.